Skip to main navigation Skip to search Skip to main content

Chemical modification of ovatodiolide revealed a promising amino-prodrug with improved pharmacokinetic profile

  • Junhong Xiang
  • , Xuemei Zhang
  • , Dehong Wang
  • , Jiaxin Li
  • , Qiuying Li
  • , Qin Wang
  • , Yahui Ding*
  • , Tianyang Chen
  • , Yuanjun Sun
  • , Shiqi Bao
  • , Jing Chen
  • , Dongmei Li
  • , Liang Wang
  • , Yue Chen
  • *Corresponding author for this work
  • Nankai University
  • Accendatech Co., Ltd.
  • Soochow University
  • Collaborative Innovation Center of Chemical Science and Engineering

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

Stepwise modification of ovatodiolide revealed a prodrug, NMP-diepoxyovatodiolide, which can provide sustained release of an active compound, substantial metabolic stability and a unique accumulation profile in the liver. Besides, NMP-diepoxyovatodiolide demonstrated therapeutic benefits in an acute autoimmune hepatitis mouse model and a broad safety window. Therefore, NMP-diepoxyovatodiolide is a very promising candidate for further development of liver-related drugs.

Original languageEnglish
Pages (from-to)11018-11021
Number of pages4
JournalChemical Communications
Volume56
Issue number75
DOIs
Publication statusPublished - 25 Sept 2020
Externally publishedYes

Fingerprint

Dive into the research topics of 'Chemical modification of ovatodiolide revealed a promising amino-prodrug with improved pharmacokinetic profile'. Together they form a unique fingerprint.

Cite this